Cassava sciences to present at the h.c. wainwright global investment conference

Austin, texas, sept. 03, 2024 (globe newswire) -- cassava sciences, inc. (nasdaq: sava), a clinical-stage biotechnology company focused on alzheimer's disease, announced today that it has been invited to present at the h.c. wainwright 26th annual global investment conference, being held in new york.
SAVA Ratings Summary
SAVA Quant Ranking